Table 2.

The list of genes deriving from infiltrating immune or nonmalignant stromal cells (n = 10): The differences in gene expression between patient tumour sample and cell lines or between patient tumour sample and normal muscle tissue.

Gene name	Comparison	Log ratio	Fold change	q-value	P value
SPP1	versus cell lines	5,608	48,757	1,22E-17	2,62E-20
	versus muscle	4,823	28,308	9,28E-19	7.30E-19
CXCR4	versus cell lines	3,870	14,621	2,00E-04	7,55E-05
	versus muscle	3,700	12,999	9,52E-22	4,67E-22
CD14	versus cell lines	3,089	8,509	8,47E-15	4,10E-17
	versus muscle	2,431	5,391	6,04E-15	8,62E-15
FOS	versus cell lines	2,984	7,911	5,19E-05	1,44E-05
	versus muscle	2,346	5,086	1,37E-04	9,04E-04
TNFAIP3	versus cell lines	2,065	4,186	3,65E-05	9,29E-06
	versus muscle	1,411	2,659	1,46E-09	4,86E-09
SOCS3	versus cell lines	1,940	3,837	1,30E-08	6,82E-10
	versus muscle	1,793	3,464	6,81E-09	2,50E-08
HSPA6	versus cell lines	1,584	2,998	1,03E-07	7,79E-09
	versus muscle	1,353	2,554	8,41E-08	3,65E-07
IL8	versus cell lines	1,368	2,582	1,55E-03	9,18E-04
	versus muscle	1,500	2,828	1,02E-07	4,49E-07
IL23A	versus cell lines	1,259	2,393	1,13E-05	2,20E-06
	versus muscle	1,336	2,525	9,77E-14	1,70E-13
STAT2	versus cell lines	1,259	2,393	1,13E-05	2,20E-06
	versus muscle	1,336	2,525	9,77E-14	1,70E-13